Skip to main content

Table 1 Clinical data on the volume of bone-filling material in procedures using Cytrans® and Bonarc®

From: Volume change after maxillary sinus floor elevation with apatite carbonate and octacalcium phosphate

Cytrans®

Age

Sex

Deficit condition (FDI)

T2 (mL)

T3 (mL)

Absorbed amount (%)

1

67

F

14–17

2.547

2.371

6.90

 

2

41

F

16

2.108

1.791

15.00

 

3

59

M

26,27

1.506

1.222

18.90

 

4

67

M

Edentulous

3.763

3.375

10.30

 

5

67

M

Edentulous

2.392

2.15

10.10

 

6

67

F

24–27

2.78

2.386

14.20

 

7

56

F

16,17

2.543

2.241

10.90

 

8

62

M

15,16

2.863

2.568

10.30

 

9

56

M

15,16

3.237

3.085

15.20

 

10

70

M

15,16

1.42

1.261

15.90

 

Bonarc®

Age

Sex

Deficit condition (FDI)

Number of sheets

T2 (mL)

T3 (mL)

Absorbed amount (%)

1

40

M

26

16

1526.0

1323

13.30

2

69

M

16

10

953.8

724.3

24.10

3

80

F

13–16

13

1239.9

1068

13.90

4

21

M

14–16

17

1621.4

1250

22.90

5

61

F

26

20

1907.6

1596

16.30

6

67

F

25–27

18

1716.8

1474

14.10

7

73

F

24–27

20

1907.6

1613.2

15.40

8

40

M

24–27

15

1430.7

1139.3

20.40

9

59

M

24–27

20

1907.6

1628.4

14.60

10

68

F

14–17

20

1907.6

1563

18.10